If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Matteo Lazzeroni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Tamoxifen Medicine & Life Sciences
Breast Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Placebos Medicine & Life Sciences
Carcinoma, Intraductal, Noninfiltrating Medicine & Life Sciences
Chemoprevention Medicine & Life Sciences
Metformin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2017

Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora's box

Lazzeroni, M., Dunn, B. K., Pruneri, G., Jereczek-Fossa, B. A., Orecchia, R., Bonanni, B. & DeCensi, A., Apr 1 2017, In : Cancer Treatment Reviews. 55, p. 1-9 9 p.

Research output: Contribution to journalReview article

Carcinoma, Intraductal, Noninfiltrating
Breast
Recurrence
Therapeutics
Mortality
Lecithins
Tea
Breast Neoplasms
Biomarkers
epigallocatechin gallate
Sputum
Non-Small Cell Lung Carcinoma
Biomarkers
MicroRNAs
DNA

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast

Pruneri, G., Lazzeroni, M., Bagnardi, V., Tiburzio, G. B., Rotmensz, N., DeCensi, A., Guerrieri-Gonzaga, A., Vingiani, A., Curigliano, G., Zurrida, S., Bassi, F., Salgado, R., Van den Eynden, G., Loi, S., Denkert, C., Bonanni, B. & Viale, G., Jan 1 2017, In : Annals of Oncology. 28, 2, p. 321-328 8 p.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Carcinoma, Intraductal, Noninfiltrating
Breast
Immunotherapy